We isolated and characterized six cDNA clones from an equine infectious anemia virus-infected cell line that displays a Rev-defective (1, 25, 26, 39, 41, 47, 54, 58) . In keeping with this interpretation of Si, transactivation of the EIAV LTR has been observed in infected cells (13, 53) , and the gene responsible for this effect was localized to a 0.8-kb fragment containing ORF S1 (14, 15, 53 (16, 17, 22, 32, 33) .
peptide antisera to detect the faulty protein, thus confirming the cDNA sequence, and to detect the normal protein in productively infected cells.
Equine infectious anemia virus (EIAV) belongs to the lentivirus group of the retrovirus family. It is related in morphology (19) , genome organization (27, 49, 56) , and sequence (9, 27, 49, 56) to the other members of that group, including the human, simian, feline, and bovine immunodeficiency viruses, visna virus, and caprine arthritis-encephalitis virus. Like the other lentiviruses, EIAV infects cells of the monocyte-macrophage lineage (28, 36) , causing a persistent, lifelong infection of its host. EIAV infection can, in some cases, be controlled by the host, resulting in asymptomatic periods that may last for many years. It would obviously be of great interest to understand the mechanism of this host control.
Replication of human immunodeficiency virus type 1 (HIV-1) is influenced by at least six genes in addition to gag, pol, and env. These are located either between pol and env or at the 3' end of the genome, and in most cases their existence is advertised by open reading frames (ORFs) of substantial length. In contrast, EIAV appears to be simpler in genetic structure. Its genomic RNA is shorter than that of HIV-1 by about 1.2 kilobases (kb), and it completely lacks the large vifand nefgenes of the latter. Three auxiliary ORFs have been pointed out in EIAV (49) . The first (Sl) is between pol and env, and its translated sequence is strikingly similar to that of HIV-1 tat. The HIV-1 Tat protein acts on sequence elements in the viral long terminal repeat (LTR) to increase viral gene expression (1, 25, 26, 39, 41, 47, 54, 58) . In keeping with this interpretation of Si, transactivation of the EIAV LTR has been observed in infected cells (13, 53) , and the gene responsible for this effect was localized to a 0.8-kb fragment containing ORF S1 (14, 15, 53) . The second EIAV ORF, S2, is immediately downstream from Si and overlaps the start of env, a position similar to that of vpu in HIV-1. There is no sequence homology with vpu, however, and no other clues to the nature of this EIAV ORF. S3 overlaps the 3' end of the env gene and may therefore be the equivalent of HIV-1 rev. The HIV-1 Rev protein affects the partitioning of specific viral RNAs between the nucleus and cytoplasm. In the presence of Rev, cytoplasmic RNA consists predominantly of unspliced genomic and partially spliced env mRNAs; in the absence of Rev, cytoplasmic RNA consists of small multiply spliced mRNAs (16, 17, 22, 32, 33) .
To understand the control of viral gene expression in EIAV-infected cells, it is necessary to delineate the structure, expression, and activity of the viral regulatory proteins, including those encoded by ORFs S1, S2, and S3. Therefore, we analyzed cDNAs from a library derived from infected cells. We found that, as in HIV-1, both the Tat and putative Rev proteins are products of two exons. Unlike HIV-1, one of the EIAV Tat-coding exons is derived from the 5' end of the genome, and translation initiation evidently occurs without an AUG codon. Also unlike HIV-1, coding exon 1 of the putative EIAV Rev protein is derived from the env gene.
MATERIALS AND METHODS Cells. EIAV-producing cultures of equine fetal kidney cells were grown in Eagle minimal essential medium containing 15% fetal bovine serum, 1% sodium pyruvate, and nonessential amino acids. EIAV-infected canine thymus cells (Cf2Th), and EIAV-infected feline (Fea) cells, and uninfected canine osteosarcoma cells (D17) were grown in Dulbecco modified Eagle medium containing 10% fetal bovine serum. Single-cell clones of Cf2Th(EIAV) were established by plating cells into 96-well dishes at 0.6 cell per well. Cells from 25 wells that contained apparent single-cell colonies were propagated. Primary horse macrophages were cultured and infected with the Wyoming strain of EIA as previously described (45a) .
RNA isolation and analysis. RNAs from tissue culture cell lines were isolated by using the guanidine isothiocyanate procedure of Chirgwin et al. (8) . RNAs from infected pri- (14) were used to study transactivation by tat. Briefly, the assay measures the activity of the gene for chloramphenicol acetyltransferase (CAT), which is dependent for its transcription upon the EIAV LTR; these are linked in plasmid pEIcat (15) . cDNAs to be tested were excised from library vector pTZ18R by using PstI and HindIII and inserted into expression plasmids pRSPA-K (sense) and pRSPA-S (antisense). These plasmids consist of Bluescript-KS (Stratagene) with the Rous sarcoma virus promoter and the simian virus 40 polyadenylation signal inserted into the multiple cloning site. pRSPA-K and pRSPA-S differ only in the orientation of these signals relative to the remaining cloning sites. To measure transactivating activity, canine (D17) cells were cotransfected with S ,ug of pEIcat and 1 ,ug of a pRSPA-K or pRSPA-S cDNA expression plasmid. CAT activity was measured after 48 h as previously described (14) .
Mutagenesis of cDNA 9. cDNA 9 was digested with BamHI, which cuts within the tat ORF of exon 1. The staggered ends were filled in with nucleoside triphosphates by using the Klenow fragment of Escherichia coli DNA polymerase, and the resulting blunt ends were ligated. The creation of a four-base insertion was verified by DNA sequencing of the product. Ile-Ser-Thr-Pro-Ile-Thr-Gln-Gln-Ser-Glu-Lys-Ser-Lys-Cys (residues 7 to 21 of the mature surface glycoprotein), was raised. All of these sera precipitate the env precursor polyprotein, as well as the mature viral protein.
Three rev ORF-derived peptides were also used. The sequence of peptide rev-1 is Lys-Ile-Asp-Pro-Gln-Gly-ProLeu-Glu-Ser-Asp-Gln-Cys (residues 29 to 40 of the predicted Rev protein); the sequence of peptide rev-2 (residues 45 to 58) is Cys-Leu-Arg-Gln-Ser-Leu-Pro-Glu-Glu-Lys-Ile-ProSer-Gln-Thr; and the sequence of peptide rev-3 (residues 66 to 76) is Cys-Gly-Pro-Gly-Pro-Thr-Gln-His-Thr-Pro-SerArg. sgp-3 and rev-1 were purchased from Multiple Peptide Systems (Pasadena, Calif.); rev-2 was purchased from Peninsula Laboratories (San Carlos, Calif.); and rev-3 was synthesized by Terry Copeland (ABL-Basic Research Program, Frederick, Md.).
sgp-3, rev-1, rev-2, and rev-3 were coupled to keyhole limpet hemocyanin through their cysteine residues (the cysteines of rev-1, rev-2, and rev-3 do not occur in the EIAV sequence and were added to facilitate coupling). Coupling and production of antisera have been described previously (45) .
Immune precipitations. Cells were grown for 3 to 5 h in methionine-and cysteine-free medium containing 10% dialyzed fetal bovine serum, [35S]methionine, and [35S]cysteine, each at 50 ,uCi/ml (600 to 1,000 Ci/mmol; Amersham Corp. Arlington Heights, Ill.). Cells were lysed in radioimmune precipitation assay buffer (20 mM Tris [pH 7.5], 2 mM EDTA, 150 mM sodium chloride; 1% sodium deoxycholate, 1% Triton X-100, 0.25% sodium dodecyl sulfate) containing 1 mM phenylmethylsulfonyl fluoride and 200 Kallikrein units of aprotinin per ml. Lysates were centrifuged for 10 min at 10,000 x g, and supernatant samples were incubated with antiserum at 4°C for 90 min in protein A-Sepharose (Pharmacia, Inc., Piscataway, N.J.). Precipitates were collected by centrifugation, washed three times in radioimmune precipitation assay buffer, boiled in gel loading dye, and loaded onto sodium dodecyl sulfate-10 to 20% polyacrylamide gels. After electrophoresis, the gels were enhanced with diphenyloxazole-dimethyl sulfoxide as previously described (45), dried, and exposed to X-ray film.
RESULTS
Northern analysis of EIAV transcripts. If EIAV tat and rev transcripts are generated by splicing patterns similar to those observed for HIV-1, these transcripts are expected to be about 1.5 kb long (1, 16, 38, 50) . We therefore examined RNAs from EIAV-producing cultures for transcripts of this size. We found that Northern blots of total RNAs from the equine, feline, and canine cell lines showed no detectable hybridizing 1.5-kb RNA, although they did have both genomic and envelope mRNAs. Poly(A) selection of the RNA before electrophoresis occasionally enabled detection of 1.5-kb RNA in the canine cells. However, in contrast to the results of others (14, 43), we did not detect 1.5-kb EIAV RNA in poly(A)+ RNA from infected equine or feline cells ( Fig. 1, lanes 1 to 3) . Similarly, primary horse macrophages infected with the virulent Wyoming strain virus contained no detectable low-molecular-weight transcripts (lanes 4 to 7). This meant that isolation of rev and tat cDNAs would be very difficult, for nearly all cDNAs would be synthesized from genomic and env messages.
For reasons unrelated to cDNA cloning, we have established single-cell clones from the EIAV-producing canine thymus cell line. Many of these clones do not produce infectious virus, and they release few or no particles into the medium. When total RNAs from several such clones were examined, the EIAV mRNA was found to be predominantly about 1.5 kb long, with some genomic and very little env mRNA ( Fig. 1 , lanes 9 to 11). Cytoplasmic RNA contained no detectable full-length or env mRNA (data not shown). Assuming similar strategies for the control of EIAV and HIV-1 gene expression, these cells appear to display a Rev-defective phenotype characterized by accumulation of fully spliced transcripts in the cytoplasm. The cell clones thus provide an abundant source of the multiply spliced RNAs that encode regulatory proteins. Analysis of cDNA clones that represent these RNAs would allow characterization of the splicing pattern and prediction of the amino acid sequences of the regulatory proteins. We reasoned that the basis for the Rev-defective phenotype would be obvious from the sequence of the cDNAs and that the authentic Rev product could be predicted. These cells provide an excellent reagent for testing of the putative product, since some HIV-1 rev mutants have been rescuable when a competent Rev protein was supplied in trans (22, 23, 31, 46) . cDNA clones. A plasmid cDNA library was constructed by using poly(A)-containing RNA from cell clone 6 ( revealed that six of these contained sequences from both the 5' and 3' ends of the EIAV genome. All six of these were analyzed in detail. Three (no. 6, 9, and 11) were completely sequenced, and the splice junctions were established in the other three (no. 1, 3, and 5). The splicing pattern was deduced by alignment of the cDNA sequences with the genomic sequence (27, 49, 56) .
With one exception, noted below, all of the analyzed clones showed the same splicing pattern and contained four exons ( Fig. 2 ; Table 1 ). Exon 1 contains 250 bases and consists of the R and U5 regions, the primer-binding site, and 118 bases between the primer-binding site and gag. The splice donor lies 5 bases upstream of the initiator methionine codon of gag. Exon 2 (142 bases) contains most of the Si ORF, which immediately follows the pol gene termination codon in the same frame. In clones 1, 3, 5, 6, and 11, the first splice acceptor is located 13 bases downstream of the pol terminator; in clone 9, the acceptor is four additional bases downstream (this is the only difference in splicing pattern among all six clones). At the 3' end of exon (52) . Bases that occur in at least 95% of the known cases are marked with asterisks. EIAV bases which do not match the consensus are underlined. The acceptor following intron la reflects the cDNA sequences of clones 1, 3, 5, 6, and 11; the acceptor following intron lb reflects the cDNA sequence of clone 9. combined ORF is shown in Fig. 3 and is compared with the sequences of the HIV-1 (1) and simian immunodeficiency virus from macaques (7) Tat proteins. Only within EIAV exon 2 (ORF Si) is there substantial homology with the other Tat proteins. Highly related regions include the EIAV se-
, which is found in very similar forms in all lentiviruses except visna virus (55) and the feline immunodeficiency virus (57) , and the EIAV sequence R-K-K-N-K-Q-R-L-K-A which, by analogy with the HIV-1 Tat protein, is probably a nuclear localization signal (48) . There are also differences between EIAV and the others. For example, the only cysteine residues in EIAV Tat are those shown above, whereas the primate lentivirus Tat proteins have a highly conserved stretch of five more, immediately upstream. In addition, upstream exons in the other lentivirus proteins do not contribute coding sequence to Tat, while in EIAV, exon 1 has considerable potential coding capacity. Unlike the primate viruses, EIAV has no downstream (beyond exon 2) Tat-coding capacity.
To determine whether the sequence shown in Fig. 3 results in a functional Tat protein, we tested the abilities of several of the cDNAs to transactivate the EIAV LTR. Two features of the sequence made this test particularly important. (i) There are no ATG triplets in either exon 1 or 2, and (ii) the sequence of cDNA 9 predicts a different Tat protein.
In that clone, the splice acceptor at the 5' end of exon 2 is 4 bases downstream from that in the other clones. In consequence, the tat ORF of exon 2 is fused with a different upstream ORF in exon 1; there are no ATG triplets in that ORF either.
To test the cDNAs for transactivating activity, the entire insert was removed from the library vector and inserted into expression vectors pRSPA-K (sense orientation) and pRSPA-S (antisense orientation). These vectors use the Rous sarcoma virus LTR as a transcriptional initiator and the simian virus 40 early-region polyadenylation signal (14) . In the sense construct, all reading frames upstream of tat have termination codons. The constructs were cotransfected into canine (D17) cells with plasmid pEIcat (15) , which contains the gene for CAT linked to the EIAV LTR. Without Tat, EIAV LTR-directed CAT activity is very low (13) . The result was that both cDNAs 3 and 11 were able to transactivate the EIAV LTR in transient assays. CAT activity was 49-to 75-fold higher in cells that received the cDNA expression plasmid than in those that received the vector alone (Fig. 4) To test the hypothesis of initiation in the long ORF of cDNA 11 exon 1, we mutagenized cDNA 9 by creating a four-base insertion within exon 1 (cDNA 9fix). In consequence, the exon 2 tat ORF was fused with a hybrid upstream ORF; the first 15 amino acids are the same as those in cDNA 11, but the next 23 residues are those of inactive cDNA 9 (Fig. 4) . The result of this mutation was to restore transactivating activity to cDNA 9. This strongly suggests that initiation occurs within the first 15 codons (bases 136 to 180) of the cDNA 11 exon 1 ORF. It also shows that large variation in the actual amino acid sequence of exon 1 Tat can be tolerated, since substitution of 23 residues affected activity only slightly (about twofold relative to that of cDNA 11).
In summary, five of six cDNAs showed the same splicing pattern between exons 1 and 2, leading to a predicted structure for EIAV tat. The longest two of these five cDNAs were able to transactivate the EIAV LTR in a transient assay. The one cDNA with a different splicing pattern, and hence a different predicted structure, was negative in this assay. There are no ATG triplets in the predicted tat sequence. Although the experiments reported here did not establish where Tat is initiated, they do suggest that it is within the first 15 codons of the exon 1 tat ORF.
Structure of the cDNAs in the exons 3 and 4. Exon 2 ends immediately following the tat termination codon. Exon 3 consists of 101 bases located just downstream from the 5' end of env, and splicing between exons 3 and 4 fuses the env reading frame in exon 3 with the ORF S3 of exon 4 to form the putative rev gene. If initiation occurs at AUG 1 of exon 3, the resulting protein would contain 30 env-derived residues. Remarkably, 17 of these are charged.
The sequence of the cDNAs in exon 4 is consistent with the Rev-defective phenotype in the cells from which the RNA was isolated. In five of the cDNAs, there was a two-base insertion relative to the genomic sequence near the 5' end of exon 4. This shifts the reading frame from ORF S3 back to env (Fig. 5C ). In addition, a single-base change converted an env UGG codon to UAG, so that termination would occur shortly after the frameshift (predicted size of the protein, about 6 kilodaltons [kDa]). In cDNA 6, there was a four-base deletion relative to the prototype genomic sequence, which also shifts the reading frame back to env (Fig. 5D ). In this case, translation could proceed to the end of the env ORF (predicted size of the protein, about 28 kDa). Thus, the sequences of all of the cDNAs show that a frameshift out of the rev ORF occurs soon after the junction between exons 3 and 4. The predicted proteins would contain only one-sixth and one-third, respectively, of the total rev ORF sequence and, hence, can be expected to lack Rev activity.
Immunoprecipitation of Rev proteins. These abortive revenv-encoded hybrid proteins should be detectable in the cells from which the original mRNA was isolated. We looked for them in immune precipitation experiments using antisera raised against the rev-and env-encoded peptides diagrammed in Fig. 5A should be recognized by six of these sera (anti-sgp-1, antiRev-1, anti-Rev-2, anti-Rev-3, anti-tm-2, and anti-tm-3) but not by anti-sgp-3. The 6-kDa frameshift product should be recognized by at least two of the sera (anti-sgp-1 and anti-Rev-1). Immune precipitation of 35S-labeled lysates of clone 6 cells revealed 6-and 28-kDa proteins with exactly these reactivities (Fig. 6A) . The 28-kDa protein was also detected in cells stably transfected with cDNA 11 (Fig 6B) . Thus, as predicted, cDNA 11 encodes two proteins: Tat (on the basis of the results shown in Fig. 4) (Fig. SB) . A protein with exactly these characteristics was readily detectable in immune precipitates of virus-producing equine fetal kidney cells but was not present in uninfected cells (Fig. 7) . We conclude that the splicing pattern seen in the cDNAs, which fuses a 30-amino-acid segment of env with the rev ORF, is not limited to Rev-defective clone 6 cells as well. The predicted sequ cDNA, without the known frameshif clone 6 cells, is shown in Fig. 8 .
B a-tm-3 a-rev-2 4 extends upstream into the env sequence in exon 3. Thus, t +-' +' the cDNAs appear to be capable of encoding two distinct products. We confirmed this by showing that cDNA 11 encodes both Tat activity and a 28-kDa rev-env frameshift protein.
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The structures of the cDNAs are compatible with the synthesis of both proteins. The combined tat ORF lacks an -68 AUG codon and is therefore likely to be translated ineffi- -43 ciently. There is only one AUG in any frame upstream of exon 3, and it is in a poor context for initiation (TxxAUGC) Fig. 5A and relative levels of the two proteins necessary for function, (ii) dodecyl sulfate-polyacryl-a difference in stability, (iii) synthesis of Tat from multiple gel. The arrows ponmtto the mRNAs (for example, the exon 1-2-4 mRNA found by Dorn 28-kDa protein (total, 11) et al. [14] ), or (iv) some combination of these possibilities.
2ntrkbute to the difference Alternatively, the lack of a strong initiator for Tat may ver gel was exposed for 4 reflect the attenuated nature of the tissue culture-adapted .6 h. The molecular weights virus, and Tat encoded by a pathogenic virus may be an the left. NRS, Normal different. We are testing this possibility. It is also possible Ifproteins from canine cells that, as in HIV-1 (1, 50), simian immunodeficiency virus were grown in "S-labeled from macaques (10), and visna virus (35), a monocistronic panel A, and precipitated EIAV rev mRNA will be found.
[sThe arrow points to the tat. The strongest evidence that the cDNAs described in v-2 and a-tm-3. The numthis study represent authentic EIAV Tat mRNA is that they r weights (10) of marker were able to transactivate the EIAV LTR when expressed in transfected cells. A cDNA isolated by Dorn et al. (14) from virus-producing feline cells had a very similar tat structure and also had transactivating activity. Our results compleence of the wild-type ment theirs in at least five ways. (i) The tat cDNA found by ting defects found in the Dorn et al. lacked an initiator AUG. It was therefore of interest to examine other infected cell types to learn whether DISCUSSION The objective of this study was to determine the structure of EIAV mRNAs that encode the viral regulatory proteins. The source of the mRNA was a cloned cell line derived from a productively infected culture of canine thymus cells. The cloned cells did not produce virus, and most of their EIAV mRNA was of the small size expected for regulatory protein messages. With HIV, such a phenotype is associated with defectiveness of the Rev protein, which, in its active state, promotes cytoplasmic accumulation of unspliced mRNAs (16, 17, 22, 32) . Thus, the uniformity of the cDNAs we observed may result from the nature of the source cells, and productively infected cells may yield additional regulatory species. Indeed, the only other EIAV cDNA isolated was derived from virus-producing feline cells and differs from ours in lacking exon 3 (14) .
The cDNAs we characterized had four exons, all of which appeared to contain coding sequences. The four exons were (i) the 5' end of the genome, (ii) the S1 (tat) ORF that immediately follows the pol gene, (iii) a small segment of env beginning 126 bases downstream from the env initiation codon, and (iv) the S3 (rev) ORF at the 3' end of the genome. Sequencing of the cDNAs showed that the tat ORF of exon 2 extends upstream into exon 1 and that the rev ORF of exon (Fig. 9) . Over a stretch of 41 EIAV residues, 27 are related to those of HIV-1 and/or HIV-2. Twelve residues are very highly conserved among all three viruses, including five from the basic domain presumed to direct nuclear localization. (iii) The cells from which the cDNA library was derived exhibited a Rev-defective phenotype. This correlates with the frameshifting mutations within exon 4 that were observed in all of the cDNAs. It is therefore our working hypothesis that the EIAV exon 3 and 4 product will show Rev activity similar to that of HIV. We are attempting to demonstrate this activity directly.
However, there is reason to be cautious about this interpretation. The presumptive EIAV Rev and HIV-1 Rev differ in the origins of their upstream coding exons. In HIV, Rev exon 1 is between pol and env and overlaps exon 1 of Tat. In both EIAV and visna virus (12, 20, 35) , exon (14) . Similarly, all of the tat mRNAs are produced by multiple splicing events, yet the Tat protein of EIAV is unique in being encoded by exons 1 and 2 and in initiating without an AUG codon. A rev ORF is identifiable in all lentiviruses, but the upstream exon differs: in the primate viruses, it overlaps the tat ORF, while in EIAV and visna virus (12, 20) it is derived from env. Thus, one must be cautious in extrapolating from one lentivirus to another. More positively, knowledge of the range of strategies and mechanisms found in the group as a whole may be helpful in unraveling particular pathways in individual viruses.
